JP2009537568A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009537568A5 JP2009537568A5 JP2009511250A JP2009511250A JP2009537568A5 JP 2009537568 A5 JP2009537568 A5 JP 2009537568A5 JP 2009511250 A JP2009511250 A JP 2009511250A JP 2009511250 A JP2009511250 A JP 2009511250A JP 2009537568 A5 JP2009537568 A5 JP 2009537568A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- phosphodiesterase
- pde4
- cognitive
- training
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80194906P | 2006-05-19 | 2006-05-19 | |
| PCT/US2007/069279 WO2007137181A2 (en) | 2006-05-19 | 2007-05-18 | Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014220896A Division JP2015042667A (ja) | 2006-05-19 | 2014-10-30 | 認知および運動のリハビリテーションのためのホスホジエステラーゼ４インヒビター |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009537568A JP2009537568A (ja) | 2009-10-29 |
| JP2009537568A5 true JP2009537568A5 (https=) | 2010-07-01 |
Family
ID=38617977
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009511250A Pending JP2009537568A (ja) | 2006-05-19 | 2007-05-18 | 認知および運動のリハビリテーションのためのホスホジエステラーゼ４インヒビター |
| JP2014220896A Pending JP2015042667A (ja) | 2006-05-19 | 2014-10-30 | 認知および運動のリハビリテーションのためのホスホジエステラーゼ４インヒビター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014220896A Pending JP2015042667A (ja) | 2006-05-19 | 2014-10-30 | 認知および運動のリハビリテーションのためのホスホジエステラーゼ４インヒビター |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP2021001B1 (https=) |
| JP (2) | JP2009537568A (https=) |
| CN (1) | CN101500559B (https=) |
| AU (1) | AU2007253734B2 (https=) |
| BR (1) | BRPI0711816A2 (https=) |
| CA (1) | CA2653042C (https=) |
| ES (1) | ES2412481T3 (https=) |
| IL (1) | IL195295A (https=) |
| MX (1) | MX2008014713A (https=) |
| SG (2) | SG172602A1 (https=) |
| WO (1) | WO2007137181A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2316531A1 (en) * | 2000-08-10 | 2011-05-04 | Cold Spring Harbor Laboratory | Augmented cognitive training |
| US7868015B2 (en) | 2000-08-10 | 2011-01-11 | Cold Spring Harbor Laboratory | Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit |
| US9931318B2 (en) | 2003-04-08 | 2018-04-03 | Dart Neuroscience (Cayman) Ltd. | Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation |
| US8153646B2 (en) | 2000-08-10 | 2012-04-10 | Dart Neuroscience (Cayman) Ltd. | Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation |
| KR20110049801A (ko) * | 2008-07-18 | 2011-05-12 | 다트 뉴로사이언시즈, 엘엘씨 | 기억 물질의 평가를 위한 방법 및 시스템 |
| WO2011114103A1 (en) | 2010-03-18 | 2011-09-22 | Biolipox Ab | Pyrimidinones for use as medicaments |
| JP6325254B2 (ja) * | 2011-09-30 | 2018-05-16 | 公益財団法人東京都医学総合研究所 | サイクリックａｍｐ応答配列結合タンパク質遺伝子解析による薬物感受性および疾患脆弱性の評価方法 |
| US8865723B2 (en) | 2012-10-25 | 2014-10-21 | Tetra Discovery Partners Llc | Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury |
| CA3103781C (en) * | 2019-12-23 | 2023-02-14 | Peter Anthony Hall | Method and system for assessing cognitive function of an individual |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2578001B2 (ja) * | 1989-12-11 | 1997-02-05 | 明治製菓株式会社 | 抗痴呆薬 |
| US5552438A (en) | 1992-04-02 | 1996-09-03 | Smithkline Beecham Corporation | Compounds useful for treating allergic and inflammatory diseases |
| EP0651824A4 (en) | 1992-04-10 | 1997-02-26 | Fox Chase Cancer Center | TRANSCRIPTION ELEMENT FOR CONTROLLING THE INCREASED GENE EXPRESSION IN MYOBLASTEN. |
| JP2001508020A (ja) * | 1994-06-02 | 2001-06-19 | シエーリング アクチエンゲゼルシヤフト | 多発性硬化症治療用のｐｄｅ ｉｖ阻害剤 |
| US6689557B1 (en) | 1994-10-07 | 2004-02-10 | Cold Spring Harbor Laboratory | Method of identifying a substance that affects long term memory and CREM/CREB/ATF-1 subfamily members |
| US5929223A (en) | 1994-10-07 | 1999-07-27 | Cold Spring Harbor Laboratory | Cloning and characterizing of genes associated with long-term memory |
| US5801030A (en) | 1995-09-01 | 1998-09-01 | Genvec, Inc. | Methods and vectors for site-specific recombination |
| DE69919179T2 (de) | 1998-09-09 | 2005-07-28 | Inflazyme Pharmaceuticals, Ltd., Richmond | Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen |
| IT1303272B1 (it) | 1998-10-29 | 2000-11-06 | Zambon Spa | Derivati triciclici inibitori della fosfodiesterasi 4 |
| EP1157007A1 (en) | 1999-02-25 | 2001-11-28 | Merck Frosst Canada Inc. | Pde iv inhibiting compounds, compositions and methods of treatment |
| US6436965B1 (en) | 2000-03-02 | 2002-08-20 | Merck Frosst Canada & Co. | PDE IV inhibiting amides, compositions and methods of treatment |
| CA2402384A1 (en) | 2000-03-16 | 2001-09-20 | Inflazyme Pharmaceuticals Ltd. | Benzylated pde4 inhibitors |
| EP2316531A1 (en) * | 2000-08-10 | 2011-05-04 | Cold Spring Harbor Laboratory | Augmented cognitive training |
| US20040224316A1 (en) * | 2000-08-10 | 2004-11-11 | Tully Timothy P. | Augmented cognitive training |
| EP1343528A2 (en) * | 2000-11-02 | 2003-09-17 | Research Foundation of City University of New York | Methods for stimulating nervous system regeneration and repair by inhibition phosphodiesterase type 4 |
| IL161317A0 (en) * | 2001-10-16 | 2004-09-27 | Memory Pharm Corp | 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| EP1482916A4 (en) * | 2002-02-07 | 2007-12-12 | Univ Miami | SCHWANNZELLEN AND PHOSPHODIESTERASE-HEMMER BASED THERAPY |
| DK1610796T3 (da) * | 2003-03-17 | 2014-07-21 | Neurohealing Pharmaceuticals Inc | Højpotent dopaminerg behandling af neurologisk svækkelse, som er forbundet med hjerneskade |
| US20090298864A1 (en) * | 2005-04-11 | 2009-12-03 | The Trustees Of Columbia University In The City Of New York | Methods for Treating Mild Cognitive Impairment |
-
2007
- 2007-05-18 ES ES07783945T patent/ES2412481T3/es active Active
- 2007-05-18 EP EP07783945A patent/EP2021001B1/en not_active Not-in-force
- 2007-05-18 WO PCT/US2007/069279 patent/WO2007137181A2/en not_active Ceased
- 2007-05-18 MX MX2008014713A patent/MX2008014713A/es active IP Right Grant
- 2007-05-18 AU AU2007253734A patent/AU2007253734B2/en not_active Ceased
- 2007-05-18 CN CN200780026381.9A patent/CN101500559B/zh not_active Expired - Fee Related
- 2007-05-18 JP JP2009511250A patent/JP2009537568A/ja active Pending
- 2007-05-18 EP EP11158676A patent/EP2377533A3/en not_active Withdrawn
- 2007-05-18 SG SG2011035813A patent/SG172602A1/en unknown
- 2007-05-18 BR BRPI0711816-3A patent/BRPI0711816A2/pt not_active IP Right Cessation
- 2007-05-18 SG SG10201407258RA patent/SG10201407258RA/en unknown
- 2007-05-18 CA CA2653042A patent/CA2653042C/en not_active Expired - Fee Related
-
2008
- 2008-11-13 IL IL195295A patent/IL195295A/en active IP Right Grant
-
2014
- 2014-10-30 JP JP2014220896A patent/JP2015042667A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009537568A5 (https=) | ||
| Salamone et al. | Mesolimbic dopamine and the regulation of motivated behavior | |
| Hasan et al. | Impaired long-term depression in schizophrenia: a cathodal tDCS pilot study | |
| Celada et al. | Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research | |
| Furlong et al. | The effect of air puff stress on c‐Fos expression in rat hypothalamus and brainstem: Central circuitry mediating sympathoexcitation and baroreflex resetting | |
| Liu et al. | The relationship between cortical inhibition, antipsychotic treatment, and the symptoms of schizophrenia | |
| McCarthy et al. | Glutamate-based depression GBD | |
| Bhagya et al. | Chronic escitalopram treatment restores spatial learning, monoamine levels, and hippocampal long-term potentiation in an animal model of depression | |
| Stickland et al. | Carotid chemoreceptor modulation of blood flow during exercise in healthy humans | |
| Ide et al. | Role of NMDA receptor GluN2D subunit in the antidepressant effects of enantiomers of ketamine | |
| EP2633868A1 (en) | Combination of alpha 7 nicotinic agonists and antipsychotics | |
| JP6668045B2 (ja) | ドラベ症候群を処置するための選択的５−ｈｔ受容体アゴニストおよびアンタゴニスト | |
| Smucny et al. | Could vagus nerve stimulation target hippocampal hyperactivity to improve cognition in schizophrenia? | |
| TN2009000277A1 (en) | 3-substituted -[1,2,3]- benzotriazinone compound for enhancing glutamatergic synaptic reponses | |
| TN2009000278A1 (en) | 3-substituted-[1,2,3] benzotriazinone compounds for enhancing glutamatergic synaptic responses | |
| Nin et al. | The effect of intra-nucleus accumbens administration of allopregnanolone on δ and γ2 GABAA receptor subunit mRNA expression in the hippocampus and on depressive-like and grooming behaviors in rats | |
| RS61442B1 (sr) | Farmaceutske kombinacije i upotrebe usmerene na poremećaje lizozomalnog skladištenja | |
| Cui et al. | Sleep patterns deteriorate over time in chronic corticosterone-treated rats | |
| Aliane et al. | Raclopride or high‐frequency stimulation of the subthalamic nucleus stops cocaine‐induced motor stereotypy and restores related alterations in prefrontal basal ganglia circuits | |
| Vachon et al. | Chlordiazepoxide, go-nogo successive discrimination and brain biogenic amines in cats | |
| Wolsh et al. | Extensive complex neocortical movement topography devolves to simple output following experimental stroke in mice | |
| Wolsh | Complex Neocortical Motor Outputs Following Injury and Insult in the Mouse Brain | |
| de Oliveira et al. | Noradrenergic inhibitory modulation in the caudal commissural NTS of the pressor response to chemoreflex activation in awake rats | |
| Lewis et al. | TMS in child and adolescent major depression | |
| Voget | Promoting deep brain stimulation as a therapeutic alternative for treatment-resistant psychiatric disorders: an animal experimental study |